« Actions have consequences: the messy aftermath of one-dose Pfizer | Main | Notes on AstraZeneca-Oxford vaccine trial results 1 »

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Ken

I assume the choice of 2 doses was based on antibody response. From https://www.theguardian.com/world/2021/jan/19/single-covid-vaccine-dose-in-israel-less-effective-than-we-hoped the second dose achieves a 6 to 12 times increase in antibodies. I guess that is because the immune system is already primed to create antibodies. The question that I raised in another comment, is what happens if the doses are spaced 2 months or more apart. Does anyone know?

I agree that any result based on a weeks data would have so few events that it would produce useless results.

Kaiser

Ken: I'm not liking the switch to looking at antibody response. For one, if that is the right measure, then all of the trials should be based on that outcome but none of them do. Secondly, how many vaccinated people did they test for antibody response? I can't imagine this is a large number. And I agree with you that a priori, all three major vaccine developers tested two doses in Phase 3. In fact, AstraZeneca changed their testing protocol mid-way through the trial to go from one to two doses!

Ken

Kaiser: I agree that antibody response is a poor surrogate especially as they don't seem to have any data linking vaccine efficacy to antibody response. Presumably at some stage Astra Zeneca realised that their vaccine in a single dose form wasn't good enough. It then didn't help that they had a manufacturing problem and initially produced half strength doses. This seems to have been a massive oversight, as AstaZeneca should have been testing the manufacturing contractors product.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)

Kaiser Fung. Business analytics and data visualization expert. Author and Speaker.
Visit my website. Follow my Twitter. See my articles at Daily Beast, 538, HBR, Wired.

See my Youtube and Flickr.
Numbers Rule Your World:
Amazon - Barnes&Noble

Numbersense:
Amazon - Barnes&Noble

Search3

  • only in Big Data

Next Events

Jan: 10 NYPL Data Science Careers Talk, New York, NY

Past Events

Aug: 15 NYPL Analytics Resume Review Workshop, New York, NY

Apr: 2 Data Visualization Seminar, Pasadena, CA

Mar: 30 ASA DataFest, New York, NY

See more here

Courses

R Fundamentals, Principal Analytics Prep

Numbersense: Statistical Reasoning in Practice, Principal Analytics Prep

Applied Analytics Frameworks & Methods, Columbia

The Art of Data Visualization, NYU

Signed copies at McNally-Jackson, NYC

Excerpts: Numbersense Ch. 1, 7, 8. NRYW

Junk Charts Blog



Link to junkcharts

Graphics design by Amanda Lee

Community